Search research articles
Contact Us
Filters
Showing results (91-100 of 128) with videos related to
Page
of 13
Sort By:
Cancers
|
September 28, 2023
Repurposing Clemastine to Target Glioblastoma Cell Stemness
Michael A Sun, Rui Yang, Heng Liu, et al.
Neuro-Oncology
|
May 13, 2021
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study
Hao-Wen Sim, Kerrie L McDonald, Zarnie Lwin, et al.
Neuro-Oncology
|
January 10, 2026
SMARCAL1 is a targetable synthetic lethal therapeutic vulnerability in ATRX-deficient gliomas that use Alternative Lengthening of Telomeres
Alexandrea Brown, Laura M Strickland, Elise N Erman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2023
The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice
Alex Broom, Leah Williams Veazey, Katherine Kenny, et al.
The Lancet. Child & Adolescent Health
|
April 2, 2023
Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial
Eric M Thompson, Daniel Landi, Michael C Brown, et al.
Neuro-Oncology
|
December 1, 2021
Establishment of patient-derived organoid models of lower-grade glioma
Kalil G Abdullah, Cylaina E Bird, Joseph D Buehler, et al.
Journal for Immunotherapy of Cancer
|
July 3, 2021
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
Aaron C Tan, Stephen J Bagley, Patrick Y Wen, et al.
Science Translational Medicine
|
February 8, 2023
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models
Scott Parker, Charlotte McDowall, Luis Sanchez-Perez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 7, 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201
Jordan R Hansford, Gauthier Bouche, Vijay Ramaswamy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2014
A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma
Yaping Shou, Douglas M Robinson, Dereck D Amakye, et al.
Page
of 13
Search research articles
Search
Showing results (91-100 of 128) with videos related to
Sort By:
Page
of 13
Cancers
|
September 28, 2023
Repurposing Clemastine to Target Glioblastoma Cell Stemness
Michael A Sun, Rui Yang, Heng Liu, et al.
Neuro-Oncology
|
May 13, 2021
A randomized phase II trial of veliparib, radiotherapy, and temozolomide in patients with unmethylated MGMT glioblastoma: the VERTU study
Hao-Wen Sim, Kerrie L McDonald, Zarnie Lwin, et al.
Neuro-Oncology
|
January 10, 2026
SMARCAL1 is a targetable synthetic lethal therapeutic vulnerability in ATRX-deficient gliomas that use Alternative Lengthening of Telomeres
Alexandrea Brown, Laura M Strickland, Elise N Erman, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
March 15, 2023
The Enduring Effects of COVID for Cancer Care: Learning from Real-Life Clinical Practice
Alex Broom, Leah Williams Veazey, Katherine Kenny, et al.
The Lancet. Child & Adolescent Health
|
April 2, 2023
Recombinant polio-rhinovirus immunotherapy for recurrent paediatric high-grade glioma: a phase 1b trial
Eric M Thompson, Daniel Landi, Michael C Brown, et al.
Neuro-Oncology
|
December 1, 2021
Establishment of patient-derived organoid models of lower-grade glioma
Kalil G Abdullah, Cylaina E Bird, Joseph D Buehler, et al.
Journal for Immunotherapy of Cancer
|
July 3, 2021
Systematic review of combinations of targeted or immunotherapy in advanced solid tumors
Aaron C Tan, Stephen J Bagley, Patrick Y Wen, et al.
Science Translational Medicine
|
February 8, 2023
Immunotoxin-αCD40 therapy activates innate and adaptive immunity and generates a durable antitumor response in glioblastoma models
Scott Parker, Charlotte McDowall, Luis Sanchez-Perez, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
August 7, 2024
Comments and Controversies in Oncology: The Tribulations of Trials Developing ONC201
Jordan R Hansford, Gauthier Bouche, Vijay Ramaswamy, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 5, 2014
A five-gene hedgehog signature developed as a patient preselection tool for hedgehog inhibitor therapy in medulloblastoma
Yaping Shou, Douglas M Robinson, Dereck D Amakye, et al.
Page
of 13